Reaktion #3683

ord-02ea72ab16be477a9f0a58c1ebfcfb1d

Reaktionsgleichung

c1ccc2c(c1)Cn1nccc1CN2
5,10-dihydro-4H-pyrazolo[5,1-c][1,4]benzodiazepine
Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Cl)c(Cl)c1
4-[(5-fluoro-2-methylbenzoyl)amino]-2-chlorobenzoyl chloride
CCN(C(C)C)C(C)C
diisopropylethylamine
Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3ccnn3Cc3ccccc32)c(Cl)c1
N-[4-(4H-Pyrazolo[5,1-c][1,4]benzodiazepin-5(10H)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    WaschenThe mixture is washed with H2 O, 1N HCl, H2O, 1M NaHCO3, brine
  2. 2
    Trocknendried (Na2SO4)
  3. 3
    Waschenthe filter cake washed with dichloromethane
  4. 4
    EinengenThe filtrate is concentrated
  5. 5
    Sonstigethe solid crystallized from ethyl acetate
  6. 6
    Sonstigeto give crystals, m.p. 137°-140° C.

Vorschrift

A mixture of 0.185 g of 5,10-dihydro-4H-pyrazolo[5,1-c][1,4]benzodiazepine, 0.391 g of 4-[(5-fluoro-2-methylbenzoyl)amino]-2-chlorobenzoyl chloride and 0.158 g of diisopropylethylamine in 10 ml of dichloromethane is stirred at room temperature overnight. The mixture is washed with H2 O, 1N HCl, H2O, 1M NaHCO3, brine and dried (Na2SO4). The solution is passed through a thin pad of hydrous magnesium silicate and the filter cake washed with dichloromethane. The filtrate is again passed through a thin pad of hydrous magnesium silicate. The filtrate is concentrated and the solid crystallized from ethyl acetate to give crystals, m.p. 137°-140° C.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05733905uspto-grants-1998_03